212 related articles for article (PubMed ID: 18997735)
61. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
Tsikitis M; Zhang Z; Edelman W; Zagzag D; Kalpana GV
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12129-34. PubMed ID: 16099835
[TBL] [Abstract][Full Text] [Related]
62. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
Bourdeaut F; Chi SN; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
[TBL] [Abstract][Full Text] [Related]
63. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
64. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors.
Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA
Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529
[TBL] [Abstract][Full Text] [Related]
65. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series.
Guillou L; Wadden C; Coindre JM; Krausz T; Fletcher CD
Am J Surg Pathol; 1997 Feb; 21(2):130-46. PubMed ID: 9042279
[TBL] [Abstract][Full Text] [Related]
66. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
67. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
[TBL] [Abstract][Full Text] [Related]
68. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
[TBL] [Abstract][Full Text] [Related]
69. Prognostic determinants in epithelioid sarcoma.
Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
[TBL] [Abstract][Full Text] [Related]
70. A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics.
Arnold MA; Arnold CA; Li G; Chae U; El-Etriby R; Lee CC; Tsokos M
Hum Pathol; 2013 May; 44(5):881-7. PubMed ID: 23245672
[TBL] [Abstract][Full Text] [Related]
71. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
[TBL] [Abstract][Full Text] [Related]
72. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
[TBL] [Abstract][Full Text] [Related]
73. Proximal-type epithelioid sarcoma in the groin presenting as a diagnostic dilemma.
Mannan AA; Rifaat AA; Kahvic M; Kapila K; Mallik M; Grover VK; Bharati C; Perry A
Pathol Oncol Res; 2010 Jun; 16(2):181-8. PubMed ID: 19757197
[TBL] [Abstract][Full Text] [Related]
74. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.
Yin X; Yang X; Wang S; Zhou J; Zhao M
Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617
[TBL] [Abstract][Full Text] [Related]
75. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
76. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
[TBL] [Abstract][Full Text] [Related]
77. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).
Kordes U; Bartelheim K; Modena P; Massimino M; Biassoni V; Reinhard H; Hasselblatt M; Schneppenheim R; Frühwald MC
Pediatr Blood Cancer; 2014 May; 61(5):919-21. PubMed ID: 24123847
[TBL] [Abstract][Full Text] [Related]
78. Cytomorphologic Spectrum of SMARCB1-Deficient Soft Tissue Neoplasms.
Schaefer IM; Al-Ibraheemi A; Qian X
Am J Clin Pathol; 2021 Jul; 156(2):229-245. PubMed ID: 33608696
[TBL] [Abstract][Full Text] [Related]
79. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
[TBL] [Abstract][Full Text] [Related]
80. Rhabdoid Variant of Myoepithelial Carcinoma, with EWSR1 Rearrangement: Expanding the Spectrum of EWSR1-Rearranged Myoepithelial Tumors.
Thway K; Bown N; Miah A; Turner R; Fisher C
Head Neck Pathol; 2015 Jun; 9(2):273-9. PubMed ID: 24993038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
